摘要：

Novel compounds having a diphenylmethane residues having inhibitory activity against (SGLT2) sodium-dependent glucose cotransporter 2 present in the intestine and kidney and containing the said compounds as active ingredients, The invention relates to a Ya prevention of diabetes The present invention relates to pharmaceutical compositions useful for the treatment. Metabolic diseases using the compounds and methods of adjusting the compounds, particularly, the present invention means to solve the above problems, provides a method for preventing or treating diabetes. [Selection] Figure Figure 1

展开